Favourable humoral but reduced cellular immune response to COVID-19 mRNA BNT162b2 vaccine in patients with childhood-onset systemic lupus erythematosusEsra Karabag Yilmaz, Ayse Agbas, Nur Canpolat, Aybuke Gunalp, Sezgin Sahin, Dogukan Ozbey, Ruveyda Gulmez, Seha Kamil Saygili, Bekir Kocazeybek, Ozgur Kasapcopur, Salim Caliskan
20 September 2024
Learning from serum markers reflecting endothelial activation: longitudinal data in childhood-onset systemic lupus erythematosusSandy C Bergkamp, Nick D Bergkamp, Mohamed Javad Wahadat, Mariken P Gruppen, Amara Nassar-Sheikh Rashid, Sander W Tas, Martine J Smit, Marjan A Versnel, J Merlijn van den Berg, Sylvia Kamphuis, Dieneke Schonenberg-Meinema
5 September 2024
Rituximab as an effective add-on maintenance therapy for disease activities in childhood-onset systemic lupus erythematosusTing-Wei Lin, Yu-Tsan Lin, Ya-Chiao Hu, Hsin-Hui Yu, Bor-Luen Chiang
19 January 2024
Treatment patterns in paediatric and adult patients with SLE: a retrospective claims database study in the USAHermine I Brunner, Aisha Vadhariya, Christina Dickson, Wallace Crandall, Casey Kar-Chan Choong, Julie A Birt, Nicolino Ruperto, Athimalaipet V Ramanan
10 July 2023
Usefulness of the lupus low disease activity state as a treatment target in childhood-onset SLEEllen M Cody, Bridget E Wilson, Ekemini A Ogbu, Jennifer L Huggins, Chen Chen, Tingting Qiu, Tracy V Ting, Francisco Flores, Bin Huang, Hermine I Brunner
30 May 2023
Targeted multiomics in childhood-onset SLE reveal distinct biological phenotypes associated with disease activity: results from an explorative studyMohamed Javad Wahadat, Sander J van Tilburg, Yvonne M Mueller, Harm de Wit, Cornelia G Van Helden-Meeuwsen, Anton W Langerak, Marike J Gruijters, Amani Mubarak, Marleen Verkaaik, Peter D Katsikis, Marjan A Versnel, Sylvia Kamphuis
3 April 2023
Autoantibody-based subgroups and longitudinal seroconversion in juvenile-onset systemic lupus erythematosusShengfang Bao, Hua Huang, Yingying Jin, Fei Ding, Zhen Yang, Xuemei Xu, Chenxi Liu, Jingyi Lu, Yanliang Jin
3 April 2023
Pharmacokinetics of hydroxychloroquine in paediatric lupus: data from a novel, direct-to-family clinical trialStephen J Balevic, Rachel Randell, Daniel Weiner, Claire Beard, Laura Eve Schanberg, Christoph P Hornik, Michael Cohen-Wolkowiez, Daniel Gonzalez, , with the CARRA Registry investigators, N Abel, K Abulaban, A Adams, M Adams, R AgbayaniSee the full list of authors
3 November 2022
Clinical measurement of lupus nephritis activity is inferior to biomarker-based activity assessment using the renal activity index for lupus nephritis in childhood-onset systemic lupus erythematosusNajla Aljaberi, Scott E Wenderfer, Arjun Mathur, Tingting Qiu, Steffy Jose, Angela Merritt, James Rose, Prasad Devarajan, Bin Huang, Hermine Brunner
13 May 2022
“There’s so much to be done”: a qualitative study to elucidate research priorities in childhood-onset systemic lupus erythematosusLaura Cannon, Anne Caliendo, Aimee Hersh, Andrea M Knight
31 March 2022